Literature DB >> 29248428

Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment.

Ming-Cheng Chang1, Yu-Li Chen2, Han-Wei Lin3, Ying-Cheng Chiang2, Chi-Fang Chang2, Shu-Feng Hsieh2, Chi-An Chen2, Wei-Zen Sun4, Wen-Fang Cheng5.   

Abstract

Ionizing radiation therapy is a well-established method of eradicating locally advanced tumors. Here, we examined whether local RT enhanced the potency of an antigen-specific DNA vaccine, and we investigated the possible underlying mechanism. Using the HPV16 E6/E7+ syngeneic TC-1 tumor, we evaluated the combination of CTGF/E7 vaccination with local irradiation with regard to synergistic antigen-specific immunity and anti-tumor effects. Tumor-bearing mice treated with local RT (6 Gy twice weekly) and CTGF/E7 DNA vaccination exhibited dramatically increased numbers of E7-specific CD8+ cytotoxic T cell precursors, higher titers of anti-E7 Abs, and significantly reduced tumor size. The combination of local RT and CTGF/E7 vaccination also elicited abscopal effects on non-irradiated local subcutaneous and distant pulmonary metastatic tumors. Local irradiation induced the expression of high-mobility group box 1 protein (HMGB-1) in apoptotic tumor cells and stimulated dendritic cell (DC) maturation, consequently inducing antigen-specific immune responses. Additionally, local irradiation eventually increased the effector-to-suppressor cell ratio in the tumor microenvironment. Overall, local irradiation enhanced the antigen-specific immunity and anti-tumor effects on local and distant metastatic tumors generated by an antigen-specific DNA vaccine. These findings suggest that the combination of irradiation with antigen-specific immunotherapy is a promising new clinical strategy for cancer therapy.
Copyright © 2017 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA vaccine; HMGB-1; cancer immunotherapy; dendritic cell; radiation

Mesh:

Substances:

Year:  2017        PMID: 29248428      PMCID: PMC5835145          DOI: 10.1016/j.ymthe.2017.11.011

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  48 in total

1.  Allogeneic compact bone-derived mesenchymal stem cell transplantation increases survival of mice exposed to lethal total body irradiation: a potential immunological mechanism.

Authors:  Shukai Qiao; Hanyun Ren; Yongjin Shi; Wei Liu
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

2.  Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis.

Authors:  Chi-An Chen; Chih-Ming Ho; Ming-Cheng Chang; Wei-Zun Sun; Yu-Li Chen; Ying-Cheng Chiang; Ming-Hong Syu; Chang-Yao Hsieh; Wen-Fang Cheng
Journal:  Mol Ther       Date:  2010-04-06       Impact factor: 11.454

Review 3.  The Basis of Oncoimmunology.

Authors:  A Karolina Palucka; Lisa M Coussens
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

4.  HMGB1 is an endogenous immune adjuvant released by necrotic cells.

Authors:  Patrizia Rovere-Querini; Annalisa Capobianco; Paola Scaffidi; Barbara Valentinis; Federica Catalanotti; Marta Giazzon; Ingrid E Dumitriu; Susanne Müller; Matteo Iannacone; Catia Traversari; Marco E Bianchi; Angelo A Manfredi
Journal:  EMBO Rep       Date:  2004-07-23       Impact factor: 8.807

5.  β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.

Authors:  Yongling Ning; Dongqin Xu; Xiaohang Zhang; Yu Bai; Jun Ding; Tongbao Feng; Shizhong Wang; Ning Xu; Keqing Qian; Yong Wang; Chunjian Qi
Journal:  Int J Cancer       Date:  2016-02-08       Impact factor: 7.396

6.  The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer.

Authors:  Xiaokun Shen; Lingzhi Hong; Huiming Sun; Minke Shi; Yong Song
Journal:  Oncol Rep       Date:  2009-09       Impact factor: 3.906

Review 7.  High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.

Authors:  Marco E Bianchi; Angelo A Manfredi
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

8.  IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways.

Authors:  Chang-Yao Hsieh; Chi-An Chen; Chia-Yen Huang; Ming-Cheng Chang; Chien-Nan Lee; Yi-Ning Su; Wen-Fang Cheng
Journal:  Mol Ther       Date:  2007-07-03       Impact factor: 11.454

9.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Authors:  Eric A Reits; James W Hodge; Carla A Herberts; Tom A Groothuis; Mala Chakraborty; Elizabeth K Wansley; Kevin Camphausen; Rosalie M Luiten; Arnold H de Ru; Joost Neijssen; Alexander Griekspoor; Elly Mesman; Frank A Verreck; Hergen Spits; Jeffrey Schlom; Peter van Veelen; Jacques J Neefjes
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

10.  Depletion of regulatory T lymphocytes reverses the imbalance between pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responses.

Authors:  Yu-Li Chen; Ming-Cheng Chang; Chi-An Chen; Han-Wei Lin; Wen-Fang Cheng; Chung-Liang Chien
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more
  17 in total

Review 1.  Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review.

Authors:  Tahir Bashir Dar; Fleury Augustin Nsole Biteghe; Ruchi Kakar-Bhanot; Eric Chekwebe Aniogo; Zaria Malindi; Olusiji Alex Akinrinmade; Nyangone Ekome Toung Chalomie; Arnaud John Kombe Kombe; Sophie Aboughe Angone; Jean Marc Ngome Ndong; Jean Delacroix Ndong
Journal:  Clin Transl Oncol       Date:  2022-08-01       Impact factor: 3.340

Review 2.  The theory of tumor ecosystem.

Authors:  Xueman Chen; Erwei Song
Journal:  Cancer Commun (Lond)       Date:  2022-06-01

Review 3.  Inflammatory microenvironment remodelling by tumour cells after radiotherapy.

Authors:  Martin McLaughlin; Emmanuel C Patin; Malin Pedersen; Anna Wilkins; Magnus T Dillon; Alan A Melcher; Kevin J Harrington
Journal:  Nat Rev Cancer       Date:  2020-03-11       Impact factor: 60.716

4.  Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer.

Authors:  Ugur Sahin; Fulvia Vascotto; Nadja Salomon; Abderaouf Selmi; Christian Grunwitz; Anthony Kong; Eliana Stanganello; Jennifer Neumaier; Jutta Petschenka; Mustafa Diken; Sebastian Kreiter; Özlem Türeci
Journal:  Cancer Immunol Immunother       Date:  2021-12-31       Impact factor: 6.630

Review 5.  Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy.

Authors:  Lukas Käsmann; Chukwuka Eze; Julian Taugner; Olarn Roengvoraphoj; Maurice Dantes; Nina-Sophie Schmidt-Hegemann; Sanziana Schiopu; Claus Belka; Farkhad Manapov
Journal:  Radiat Oncol       Date:  2020-07-09       Impact factor: 3.481

6.  Optimal combination treatment regimens of vaccine and radiotherapy augment tumor-bearing host immunity.

Authors:  Fayun Zhang; Zifeng Zheng; Apurba Kumar Barman; Zihao Wang; Luyao Wang; Wenfeng Zeng; Luoyang Wang; Yan Qin; Asmita Pandey; Chunling Zhang; Wei Liang
Journal:  Commun Biol       Date:  2021-01-19

7.  Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma.

Authors:  Xiaofeng Xu; Diyu Chen; Xiaode Feng; Jiating Hu; Jiangzhen Ge; Chaobiao Yan; Deguo Zhang; Zhenan Ling; Jianzhong Chen; Jian Wu
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

Review 8.  Local Destruction of Tumors and Systemic Immune Effects.

Authors:  Karl-Göran Tranberg
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

9.  mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment.

Authors:  Yu-Li Chen; Han-Wei Lin; Nai-Yun Sun; Jr-Chi Yie; Hsueh-Chih Hung; Chi-An Chen; Wei-Zen Sun; Wen-Fang Cheng
Journal:  Cancers (Basel)       Date:  2019-05-02       Impact factor: 6.639

Review 10.  Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Authors:  Melissa Gamat-Huber; Donghwan Jeon; Laura E Johnson; Jena E Moseman; Anusha Muralidhar; Hemanth K Potluri; Ichwaku Rastogi; Ellen Wargowski; Christopher D Zahm; Douglas G McNeel
Journal:  Cancers (Basel)       Date:  2020-09-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.